Cargando…

Stroke and Bleeding Risk Assessment in Atrial Fibrillation: Where Are We Now?

Most important international guidelines recommend the use of CHA(2)DS(2)-VASc and HAS-BLED scores for stroke and bleeding risk assessments in atrial fibrillation (AF) patients, respectively. The 2020 AF guidelines of European Society of Cardiology have revised the definition of “C: congestive heart...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuo, Ling, Chan, Yi-Hsin, Liao, Jo-Nan, Chen, Shih-Ann, Chao, Tze-Fan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Cardiology 2021
Materias:	State of the Art Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326217/ https://www.ncbi.nlm.nih.gov/pubmed/34227269 http://dx.doi.org/10.4070/kcj.2021.0170

Ejemplares similares

Active surveillance in prostate cancer management: where do we stand now?
por: Dragan, Jędrzej, et al.
Publicado: (2020)

Stroke Prevention in Atrial Fibrillation: Where are We Now?
por: Ahmad, Yousif, et al.
Publicado: (2012)

Psychiatric manifestations of neurologic disease: where are we headed?
por: Lyketsos, Constantin G., et al.
Publicado: (2007)

Nature and nurture in neuropsychiatric genetics: where do we stand?
por: Dick, Danielle M., et al.
Publicado: (2010)

Prediction of treatment outcomes in psychiatry—where do we stand ?
por: McMahon, Francis J.
Publicado: (2014)

The impact of the digital revolution  on human brain and behavior: where  do we stand? 
por: Korte, Martin
Publicado: (2020)

Immunosuppression in kidney transplant recipients with COVID-19 infection – where do we stand and where are we heading?
por: Daoud, Ahmed, et al.
Publicado: (2021)

Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal
por: Lip, Gregory Y H, et al.
Publicado: (2023)

MicroRNAs and metabolic disorders – where are we heading?
por: Sliwinska, Agnieszka, et al.
Publicado: (2017)

Atrial Fibrillation after Cardiac Surgery: Where are we now?
por: Patel, Dimpi, et al.
Publicado: (2008)

Prevention of Dementia in Patients with Atrial Fibrillation
por: Kim, Daehoon, et al.
Publicado: (2021)

Affective immunology: where emotions and the immune response converge
por: D'Acquisto, Fulvio
Publicado: (2017)

Optimal Rhythm Control Strategy in Patients With Atrial Fibrillation
por: Kim, Daehoon, et al.
Publicado: (2022)

Cardiac parasympathetic modulation in the setting of radiofrequency ablation for atrial fibrillation
por: Osório, Thiago G., et al.
Publicado: (2019)

Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention: A Consensus Document From the Academic Research Consortium for High Bleeding Risk
por: Urban, Philip, et al.
Publicado: (2019)

Progress in atrial fibrillation ablation during 25 years of Europace journal
por: Boersma, Lucas, et al.
Publicado: (2023)

The Importance of Arrhythmia Burden for Outcomes and Management Related to Catheter Ablation of Atrial Fibrillation
por: Sánchez-Somonte, Paula, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease, metabolic syndrome, and type 2 diabetes mellitus: where do we stand today?
por: Mitrovic, Bojan, et al.
Publicado: (2022)

Silent cerebral lesions following catheter ablation for atrial fibrillation: a state-of-the-art review
por: Calvert, Peter, et al.
Publicado: (2023)

Common Pathophysiology in Cancer, Atrial Fibrillation, Atherosclerosis, and Thrombosis: JACC: CardioOncology State-of-the-Art Review
por: Leiva, Orly, et al.
Publicado: (2021)

Thrombus composition and thrombolysis resistance in stroke
por: Ho-Tin-Noé, Benoit, et al.
Publicado: (2023)

Where are we now with aphasia after Stroke?
por: Enderby, Pam, et al.
Publicado: (2020)

Current stroke rehabilitation services and physiotherapy research in South Africa
por: Ntsiea, Mokgobadibe V.
Publicado: (2019)

Glycemic status and risks of thromboembolism and major bleeding in patients with atrial fibrillation
por: Chan, Yi-Hsin, et al.
Publicado: (2020)

Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023)

Where are we now?
Publicado: (1977)

Posttranslational modifications of titin from cardiac muscle: how, where, and what for?
por: Koser, Franziska, et al.
Publicado: (2019)

Aging with Down Syndrome—Where Are We Now and Where Are We Going?
por: Alldred, Melissa J., et al.
Publicado: (2021)

Atrial Myopathy
por: Shen, Mark J., et al.
Publicado: (2019)

Modified Taiwan Atrial Fibrillation Score for the Prediction of Incident Atrial Fibrillation
por: Liao, Jo-Nan, et al.
Publicado: (2022)

Triple therapy in patients with atrial fibrillation and acute coronary syndrome or percutaneous coronary intervention/stenting
por: Kozieł, Monika, et al.
Publicado: (2020)

NIPPV: Where Are We Now?
por: Fakharian, Atefeh, et al.
Publicado: (2013)

Onchodermatitis: Where Are We Now?
por: Murdoch, Michele E.
Publicado: (2018)

Protective Renal Effects of Atrial Natriuretic Peptide: Where Are We Now?
por: Choi, Marcelo Roberto, et al.
Publicado: (2021)

AI in medicine: Where are we now and where are we going?
por: Shandhi, Md Mobashir Hasan, et al.
Publicado: (2022)

Intrahepatic Cholangiocarcinoma—Where Are We Now and Where Are We Going to?
por: Wasilewicz, Michał P., et al.
Publicado: (2023)

Novel Treatment for Graft-versus-Host Disease
por: Inamoto, Yoshihiro, et al.
Publicado: (2021)

Combination Strategies to Improve Targeted Radionuclide Therapy
por: Chan, Tiffany G., et al.
Publicado: (2020)

Cardiac complications of COVID-19 vaccination: now we know more
por: Verdecchia, Paolo, et al.
Publicado: (2022)

Leap or lag: left atrial appendage closure and guidelines
por: Camm, A John
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_iq6ukbfm569jo23rd3mn89onpg